![]()
References
Genomics
miRNA Target Status
Predicted Targets
Summary Value | Count of predictions: | 39044 | Count of gene targets: | 14899 | Count of transcripts: | 34481 | Interacting mature miRNAs: | hsa-miR-4655-3p, hsa-miR-4655-5p | Prediction methods: | Microtar, Miranda, Pita, Rnahybrid, Targetscan | Result types: | miRGate_prediction | |
The detailed report is available here: | ![]() | Full Report | ![]() | CSV | ![]() | TAB | ![]() | Printer |
miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/). For more information about miRGate, see PMID:25858286 or access the full paper here. |
Expression
RNA-SEQ Expression
High: > 1000 TPM value
Medium: Between 11 and 1000 TPMLow: Between 0.5 and 10 TPM Below Cutoff: < 0.5 TPM
alimentary part of gastrointestinal system | circulatory system | endocrine system | exocrine system | hemolymphoid system | hepatobiliary system | integumental system | musculoskeletal system | nervous system | renal system | reproductive system | respiratory system | sensory system | adipose tissue | appendage | |
High | |||||||||||||||
Medium | 1 | 3 | 11 | 1 | 1 | ||||||||||
Low | 29 | 12 | 19 | 10 | 127 | 12 | 47 | 15 | 40 | 22 | 27 | 42 | 2 | 6 | 9 |
Below cutoff | 19 | 6 | 7 | 2 | 22 | 3 | 12 | 24 | 19 | 10 | 16 | 19 | 2 | 1 |
Sequence
Nucleotide Sequences
Reference Sequences
RefSeq Acc Id: | ENST00000580817 | ||||||||
RefSeq Status: | |||||||||
Type: | CODING | ||||||||
Position: |
|
RefSeq Acc Id: | NR_039799 | ||||||||||||||||||||||||
RefSeq Status: | PROVISIONAL | ||||||||||||||||||||||||
Type: | NON-CODING | ||||||||||||||||||||||||
Position: |
|
||||||||||||||||||||||||
Sequence: |
Clinical Variants
Name | Type | Condition(s) | Position(s) | Clinical significance |
GRCh38/hg38 7p22.3-q36.3(chr7:54185-159282390)x1 | copy number loss | See cases [RCV000135401] | Chr7:54185..159282390 [GRCh38] Chr7:54185..159075079 [GRCh37] Chr7:149268..158767840 [NCBI36] Chr7:7p22.3-q36.3 |
pathogenic |
GRCh38/hg38 7p22.3-15.2(chr7:54185-26827634)x3 | copy number gain | See cases [RCV000136557] | Chr7:54185..26827634 [GRCh38] Chr7:54185..26867253 [GRCh37] Chr7:149268..26833778 [NCBI36] Chr7:7p22.3-15.2 |
pathogenic |
GRCh38/hg38 7p22.3-22.2(chr7:54185-3324143)x1 | copy number loss | See cases [RCV000136789] | Chr7:54185..3324143 [GRCh38] Chr7:54185..3363775 [GRCh37] Chr7:149268..3330301 [NCBI36] Chr7:7p22.3-22.2 |
pathogenic |
GRCh38/hg38 7p22.3(chr7:1330987-2530644)x1 | copy number loss | See cases [RCV000136673] | Chr7:1330987..2530644 [GRCh38] Chr7:1370623..2570278 [GRCh37] Chr7:1337149..2536804 [NCBI36] Chr7:7p22.3 |
uncertain significance |
GRCh38/hg38 7p22.3-22.1(chr7:54185-6638027)x3 | copy number gain | See cases [RCV000136731] | Chr7:54185..6638027 [GRCh38] Chr7:54185..6677658 [GRCh37] Chr7:149268..6644183 [NCBI36] Chr7:7p22.3-22.1 |
pathogenic |
GRCh38/hg38 7p22.3(chr7:791215-1993065)x3 | copy number gain | See cases [RCV000136691] | Chr7:791215..1993065 [GRCh38] Chr7:830852..2032700 [GRCh37] Chr7:797378..1999226 [NCBI36] Chr7:7p22.3 |
uncertain significance |
GRCh38/hg38 7p22.3-21.3(chr7:45130-7252065)x3 | copy number gain | See cases [RCV000137524] | Chr7:45130..7252065 [GRCh38] Chr7:45130..7291696 [GRCh37] Chr7:140213..7258221 [NCBI36] Chr7:7p22.3-21.3 |
pathogenic |
GRCh38/hg38 7p22.3(chr7:1085248-2530644)x4 | copy number gain | See cases [RCV000137818] | Chr7:1085248..2530644 [GRCh38] Chr7:1124884..2570278 [GRCh37] Chr7:1091410..2536804 [NCBI36] Chr7:7p22.3 |
uncertain significance |
GRCh38/hg38 7p22.3-15.3(chr7:45130-25221165)x3 | copy number gain | See cases [RCV000137824] | Chr7:45130..25221165 [GRCh38] Chr7:45130..25260784 [GRCh37] Chr7:140213..25227309 [NCBI36] Chr7:7p22.3-15.3 |
pathogenic |
GRCh38/hg38 7p22.3(chr7:689554-2031521)x3 | copy number gain | See cases [RCV000138319] | Chr7:689554..2031521 [GRCh38] Chr7:729191..2071156 [GRCh37] Chr7:695717..2037682 [NCBI36] Chr7:7p22.3 |
uncertain significance |
GRCh38/hg38 7p22.3-15.2(chr7:1698124-27207295)x3 | copy number gain | See cases [RCV000143060] | Chr7:1698124..27207295 [GRCh38] Chr7:1737760..27246914 [GRCh37] Chr7:1704286..27213439 [NCBI36] Chr7:7p22.3-15.2 |
pathogenic |
GRCh38/hg38 7p22.3-22.2(chr7:54165-3258775)x1 | copy number loss | See cases [RCV000142995] | Chr7:54165..3258775 [GRCh38] Chr7:54165..3298407 [GRCh37] Chr7:149248..3264933 [NCBI36] Chr7:7p22.3-22.2 |
pathogenic |
GRCh38/hg38 7p22.3-22.2(chr7:45130-3406236)x3 | copy number gain | See cases [RCV000143175] | Chr7:45130..3406236 [GRCh38] Chr7:45130..3445868 [GRCh37] Chr7:140213..3412394 [NCBI36] Chr7:7p22.3-22.2 |
uncertain significance |
GRCh38/hg38 7p22.3-15.2(chr7:43360-27196404)x3 | copy number gain | See cases [RCV000143586] | Chr7:43360..27196404 [GRCh38] Chr7:43360..27236023 [GRCh37] Chr7:138443..27202548 [NCBI36] Chr7:7p22.3-15.2 |
pathogenic |
GRCh38/hg38 7p22.3-14.1(chr7:54185-41875885)x3 | copy number gain | See cases [RCV000051159] | Chr7:54185..41875885 [GRCh38] Chr7:54185..41915483 [GRCh37] Chr7:149268..41882008 [NCBI36] Chr7:7p22.3-14.1 |
pathogenic |
GRCh38/hg38 7p22.3-22.1(chr7:45130-5880375)x1 | copy number loss | See cases [RCV000052249] | Chr7:45130..5880375 [GRCh38] Chr7:45130..5920006 [GRCh37] Chr7:140213..5886532 [NCBI36] Chr7:7p22.3-22.1 |
pathogenic |
GRCh38/hg38 7p22.3-q36.3(chr7:53985-159282531)x1 | copy number loss | See cases [RCV000052250] | Chr7:53985..159282531 [GRCh38] Chr7:53985..159075220 [GRCh37] Chr7:149068..158767981 [NCBI36] Chr7:7p22.3-q36.3 |
pathogenic |
GRCh38/hg38 7p22.3-22.1(chr7:45130-6270185)x3 | copy number gain | See cases [RCV000053527] | Chr7:45130..6270185 [GRCh38] Chr7:45130..6309816 [GRCh37] Chr7:140213..6276341 [NCBI36] Chr7:7p22.3-22.1 |
pathogenic |
GRCh38/hg38 7p22.3-15.3(chr7:53985-24361531)x3 | copy number gain | See cases [RCV000053528] | Chr7:53985..24361531 [GRCh38] Chr7:53985..24401150 [GRCh37] Chr7:149068..24367675 [NCBI36] Chr7:7p22.3-15.3 |
pathogenic |
GRCh38/hg38 7p22.3-21.3(chr7:54185-8274834)x3 | copy number gain | Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053529]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053529]|See cases [RCV000053529] | Chr7:54185..8274834 [GRCh38] Chr7:54185..8314464 [GRCh37] Chr7:149268..8280989 [NCBI36] Chr7:7p22.3-21.3 |
pathogenic |
GRCh38/hg38 7p22.3-14.2(chr7:54185-37089712)x3 | copy number gain | See cases [RCV000053530] | Chr7:54185..37089712 [GRCh38] Chr7:54185..37129317 [GRCh37] Chr7:149268..37095842 [NCBI36] Chr7:7p22.3-14.2 |
pathogenic |
Additional Information
External Database Links
Database | Acc Id | Source(s) |
COSMIC | MIR4655 | COSMIC |
Ensembl Genes | ENSG00000265089 | Ensembl, ENTREZGENE |
Ensembl Transcript | ENST00000580817 | ENTREZGENE |
GTEx | ENSG00000265089 | GTEx |
HGNC ID | HGNC:41754 | ENTREZGENE |
Human Proteome Map | MIR4655 | Human Proteome Map |
miRBase | MI0017283 | ENTREZGENE |
NCBI Gene | 100616160 | ENTREZGENE |
RNAcentral | URS00003B66C6 | RNACentral |
URS0000576E6E | RNACentral | |
URS000075EACC | RNACentral |